European Commission logo
español español
CORDIS - Resultados de investigaciones de la UE
CORDIS

AI guidance for robot-assisted eye surgery

Descripción del proyecto

La inteligencia artificial como guía para la cirugía ocular asistida por robot

Las enfermedades retinianas son la principal causa de lesiones visuales en los países industrializados y un problema de salud pública cada vez mayor. Llevar a cabo actuaciones quirúrgicas directamente en la retina con instrumentos microquirúrgicos ultrafinos y con una visión limitada es un problema muy complicado que requiere cirujanos altamente capacitados y experimentados. En el proyecto GEYEDANCE, financiado con fondos europeos, se introducirán métodos de inteligencia artificial en la robótica quirúrgica para ofrecer una asistencia avanzada al usuario y reducir la carga mental y física de los cirujanos. El equipo de GEYEDANCE generará una tecnología tangible y «próxima a la certificación» y llevará a cabo un primer ensayo clínico. En última instancia, GEYEDANCE ayudará a los cirujanos de retina a optimizar su labor y contribuirá a mejorar los resultados quirúrgicos en beneficio de los futuros pacientes.

Objetivo

"Retina indications are the leading cause of visual impairment in industrialized countries and posing a big unmet socio-economic challenge. Performing surgical actions directly at the retina - one of the most delicate and sensitive areas of the human body - with ultra-thin microsurgical instruments and with a limited view makes retina surgery a very challenging discipline with surgeons working at the limit of what is possible, requiring years of training and experience to reach proficiency.
The GEYEDANCE project is directly addressing this need by translating methods from Artificial Intelligence to the area of surgical robotics, together to be used for an advanced user support for reducing the mental and physical load of the surgeon. Work in the project is building on two existing main blocks - the CE certified robot platform PSS from project partner Preceyes, and a prototype for a Common-Path OCT system with extended measurement depth from partner ACMIT. For the AI-components to be developed, two European leading groups in this domain - ALTAIR/University of Verona and ARTORG/University of Bern - are part of the consortium. Seamless involvement of key stakeholders during the complete development phase is indispensable for a meaningful outcome, and thus a prominent board of world-wide leading eye surgeons, led by partner University of Ferrara, will provide user insight and evaluate the resulting advanced robotic solution. Development and validation of the GEYEDANCE system is strongly supported by industrial partners Carl Zeiss AG and Carl Zeiss Meditec AG.
In-line with the concept of the “Innovation Actions” instrument, the project aims to generate tangible and “close-to-certification"" technology reaching a TRL of 7 (or even higher), being evaluated in the framework of a first clinical trial. All together, the planned AI-based guidance system GEYEDANCE will help the consortium to further consolidate their leading position worldwide, will help retinal surgeons to optimize their task, and finally will help the patient by contributing to a better surgical outcome."

Palabras clave

Coordinador

ACMIT GMBH
Aportación neta de la UEn
€ 990 000,00
Dirección
VIKTOR KAPLAN STRASSE 2
2700 Wiener Neustadt
Austria

Ver en el mapa

Pyme

Organización definida por ella misma como pequeña y mediana empresa (pyme) en el momento de la firma del acuerdo de subvención.

Región
Ostösterreich Niederösterreich Niederösterreich-Süd
Tipo de actividad
Other
Enlaces
Coste total
€ 990 000,00

Participantes (5)

Socios (1)